NEW YORK (GenomeWeb News) – German molecular diagnostics firm SIRS-Lab said today that it will use a PCR technology platform from DxS in a sepsis pathogen-detection test in the European Union under a new licensing agreement.
 
SIRS-Lab will use the DxS Scorpions Technology with its Signature sepsis prediction and monitoring test, which it plans to make widely available in the EU in 2009. The companies also have agreed to include an option in the license that would allow SIRS-Lab to use the DxS PCR technology worldwide.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

US Attorney General Jeff Sessions is considering using DNA tests to determine relatedness between adult and child migrants, the Daily Caller reports.

Bloomberg reports that Brainstorm Cell Therapeutics plans to offer a treatment it is developing under the "right to try" law for hundreds of thousands of dollars.

In Nature this week: expansion of disease-resistance genes among long-lived oak trees, and more.

In a proof-of-concept study, researchers report being able to determine age from dried bloodstains, Discover's D-brief blog reports.